This is/was a big fish, and needed patients. They
Post# of 154420
(Total Views: 554)
Posted On: 12/28/2019 3:07:11 AM
This is/was a big fish, and needed patients. They were not into big fish. They were all penny flippers. They would have been gone sooner or later.
They were flipping to reduce cost maybe %5 and keep setting target expected low prices. For the same reason, a %30 or %40 jump would be a huge victory. As I see, NOT visionary individuals with ability see a far distance, having some risk tolerance.
If they didn't sell at .30 they would have sold on the jump to .4x and still miss. So, it was just a matter of time in a uptrend for them to get out.
There are many stocks out there with which to make a few percent. So, they can recover any loss.
Loading/getting-back this is a huge mistake for them. If it drops 30%, they will sell again. This kinda stock needs a different level of risk appetite.
Now, they don't need to worry and keep calculating the upper bound. So, it's a win for them as well.
We can move on, back to caring about our own pocket and making some real money.
I think based on the price movement, we should see some exercising their options, and corp needing less money to raise. I'm thinking expecting $1.35 to $3 in the months, is quite reasonable, just by expecting a NASH partnership catalyst, Cancer BTD and more surprises.
GLTA
They were flipping to reduce cost maybe %5 and keep setting target expected low prices. For the same reason, a %30 or %40 jump would be a huge victory. As I see, NOT visionary individuals with ability see a far distance, having some risk tolerance.
If they didn't sell at .30 they would have sold on the jump to .4x and still miss. So, it was just a matter of time in a uptrend for them to get out.
There are many stocks out there with which to make a few percent. So, they can recover any loss.
Loading/getting-back this is a huge mistake for them. If it drops 30%, they will sell again. This kinda stock needs a different level of risk appetite.
Now, they don't need to worry and keep calculating the upper bound. So, it's a win for them as well.
We can move on, back to caring about our own pocket and making some real money.
I think based on the price movement, we should see some exercising their options, and corp needing less money to raise. I'm thinking expecting $1.35 to $3 in the months, is quite reasonable, just by expecting a NASH partnership catalyst, Cancer BTD and more surprises.
GLTA
(0)
(0)